Literature DB >> 29637745

Rubinstein-Taybi syndrome: New neuroradiological and neuropsychiatric insights from a multidisciplinary approach.

Paola F Ajmone1, Sabrina Avignone2, Cristina Gervasini3, Antonella Giacobbe1, Fedrico Monti1, Antonella Costantino1, Susanna Esposito4, Paola Marchisio5, Fabio Triulzi2, Donatella Milani5.   

Abstract

Rubinstein-Taybi syndrome is a rare, autosomal dominant, plurimalformative disorder that is clinically characterized by intellectual disability and a wide spectrum of congenital anomalies; facial dysmorphisms are typical, and broad thumbs and great toes are particularly distinctive. Its genetic basis is only partially known, with a detection rate of approximately 65-70%; specifically, microdeletions or mutations in the CREBBP or EP300 genes can be found. Much is known about its clinical features and health-care protocols, but some areas of clinical knowledge are currently unsolved. In particular, few efforts have been made until now to understand the variability in the neuropsychological and neurobehavioral profile and to deepen knowledge of the neuroradiological malformative pattern. Consequently, little is known about the possible genotype-phenotype correlations of these issues. Here, we report clinical and genetic data from a cohort of 23 RSTS Italian patients. The most common features in brain magnetic resonance imaging (MRI) were dysmorphic aspects of the corpus callosum (73.6%) with or without minor dysmorphisms of cerebellar vermis, periventricular posterior white matter hyperintensity, and other less common anomalies. The most interesting feature on the whole spine MRI scans was the tendency for a low-lying conus medullaris without terminal filum thickening. These data will help to improve neuropsychiatric and neuroradiological knowledge and highlight specific genotype-phenotype correlations.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  CREBBP gene; EP300 gene; MRI anomalies; RSTS; behavioral phenotype; intellectual disability; tethered cord

Mesh:

Substances:

Year:  2018        PMID: 29637745     DOI: 10.1002/ajmg.b.32628

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  8 in total

1.  NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain.

Authors:  Sanxiong Liu; Kimberly A Aldinger; Chi Vicky Cheng; Takae Kiyama; Mitali Dave; Hanna K McNamara; Wukui Zhao; James M Stafford; Nicolas Descostes; Pedro Lee; Stefano G Caraffi; Ivan Ivanovski; Edoardo Errichiello; Christiane Zweier; Orsetta Zuffardi; Michael Schneider; Antigone S Papavasiliou; M Scott Perry; Jennifer Humberson; Megan T Cho; Astrid Weber; Andrew Swale; Tudor C Badea; Chai-An Mao; Livia Garavelli; William B Dobyns; Danny Reinberg
Journal:  Mol Cell       Date:  2021-10-11       Impact factor: 17.970

2.  Transcriptome Analysis of iPSC-Derived Neurons from Rubinstein-Taybi Patients Reveals Deficits in Neuronal Differentiation.

Authors:  Luciano Calzari; Matteo Barcella; Valentina Alari; Daniele Braga; Rafael Muñoz-Viana; Cristina Barlassina; Palma Finelli; Cristina Gervasini; Angel Barco; Silvia Russo; Lidia Larizza
Journal:  Mol Neurobiol       Date:  2020-06-20       Impact factor: 5.590

3.  The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration.

Authors:  Melanie Schoof; Michael Launspach; Dörthe Holdhof; Lynhda Nguyen; Verena Engel; Severin Filser; Finn Peters; Jana Immenschuh; Malte Hellwig; Judith Niesen; Volker Mall; Birgit Ertl-Wagner; Christian Hagel; Michael Spohn; Beat Lutz; Jan Sedlacik; Daniela Indenbirken; Daniel J Merk; Ulrich Schüller
Journal:  Acta Neuropathol Commun       Date:  2019-12-05       Impact factor: 7.801

4.  Clinical exome sequencing identifies novel CREBBP variants in 18 Chinese Rubinstein-Taybi Syndrome kids with high frequency of polydactyly.

Authors:  Sha Yu; Bingbing Wu; Yanyan Qian; Ping Zhang; Yulan Lu; Xinran Dong; Qing Wang; Xuemei Zhao; Renchao Liu; Wenhao Zhou; Huijun Wang
Journal:  Mol Genet Genomic Med       Date:  2019-10-22       Impact factor: 2.183

Review 5.  The behavioral phenotype of Rubinstein-Taybi syndrome: A scoping review of the literature.

Authors:  Neelam Awan; Effie Pearson; Lauren Shelley; Courtney Greenhill; Joanne Tarver; Jane Waite
Journal:  Am J Med Genet A       Date:  2022-06-21       Impact factor: 2.578

6.  Histone Deacetylase Inhibitors Ameliorate Morphological Defects and Hypoexcitability of iPSC-Neurons from Rubinstein-Taybi Patients.

Authors:  Valentina Alari; Paolo Scalmani; Paola Francesca Ajmone; Sara Perego; Sabrina Avignone; Ilaria Catusi; Paola Adele Lonati; Maria Orietta Borghi; Palma Finelli; Benedetta Terragni; Massimo Mantegazza; Silvia Russo; Lidia Larizza
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 7.  Rubinstein-Taybi Syndrome: A Model of Epigenetic Disorder.

Authors:  Julien Van Gils; Frederique Magdinier; Patricia Fergelot; Didier Lacombe
Journal:  Genes (Basel)       Date:  2021-06-24       Impact factor: 4.096

8.  Genetic and clinical heterogeneity in Korean patients with Rubinstein-Taybi syndrome.

Authors:  Naye Choi; Hwa Young Kim; Byung Chan Lim; Jong-Hee Chae; Soo Yeon Kim; Jung Min Ko
Journal:  Mol Genet Genomic Med       Date:  2021-08-24       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.